Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-Week vs Six-Week Antibiotic Therapy in the Management of Nonsurgically Treated Diabetic Foot Osteomyelitis: Protocol for a Multicentric, Single-Blind Randomized Clinical Trial.

JMIR research protocols·2026
Same author

Authors' Response comment on Comparative analysis of retinal thickness between type 1 and type 2 diabetes Mellitus patients with similar disease duration - A cross-sectional study.

Indian journal of ophthalmology·2026
Same author

Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study).

Cureus·2026
Same author

Forecasting tuberculosis through mechanistic learning of transmission dynamics: Insights from a case study in India.

Computers in biology and medicine·2025
Same author

Comparative analysis of retinal thickness between type 1 and type 2 diabetes mellitus patients with similar disease duration: A cross-sectional study.

Indian journal of ophthalmology·2025
Same author

Use of Ambulatory Glucose Profile in Monitoring and Improved Control of Gestational Diabetes Mellitus When Compared to Self-monitoring of Blood Glucose.

The Journal of the Association of Physicians of India·2025

Related Experiment Video

Updated: May 10, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Primary cold agglutinin disease: a case report.

Susanta Kumar Das1, Amritava Ghosh, Niloy Banerjee

  • 1Department of Medicine, RG Kar Medical College and Hospital, Kolkata.

Journal of the Indian Medical Association
|June 7, 2013
PubMed
Summary

Primary cold agglutinin disease, a rare autoimmune hemolytic anemia, affects the elderly. This case highlights a decade-long struggle with severe symptoms, emphasizing conservative management for this specific condition.

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Related Experiment Videos

Last Updated: May 10, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Area of Science:

  • Hematology
  • Immunology
  • Internal Medicine

Background:

  • Cold agglutinin disease (CAD) is an autoimmune hemolytic anemia characterized by autoantibodies against red blood cells that activate at low temperatures.
  • Primary CAD is diagnosed when no underlying or associated condition is identified, typically affecting the elderly population.
  • The defining feature is the temperature-dependent reactivity of the autoantibody, which binds red cells poorly at 37°C but strongly at lower temperatures.

Observation:

  • A case presentation of a patient experiencing severe pallor, jaundice, and reddish urine over a 10-year period.
  • Symptoms were notably exacerbated during the winter season, consistent with temperature-dependent red blood cell destruction.
  • The patient's presentation over a decade led to a diagnosis of primary cold agglutinin disease.

Findings:

  • The patient was diagnosed with primary cold agglutinin disease based on clinical presentation and characteristic autoantibody behavior.
  • The chronic nature of the condition, spanning 10 years, underscores the persistent challenges in managing CAD.
  • Diagnostic criteria for primary CAD were met, excluding secondary causes.

Implications:

  • This case emphasizes the importance of recognizing chronic cold agglutinin disease, even in the absence of apparent triggers.
  • Conservative management strategies can be effective for long-term control of symptoms in primary CAD.
  • Further research into the long-term effects and optimal conservative treatments for primary CAD is warranted.